Strides Pharma Science rallied 3.13% to Rs 1,395.80 after the company’s step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore has received US Food & Drug Administration (USFDA) approval for Fluoxetine tablets.
| Subscribe To Our Free Newsletter |
